Washington University in St. Louis (WU)
Studying the impact invariant natural killer T cells (iNKT cells) have in malignancy and graft versus host disease. Translating pre-clinical studies of iNKT cell pathophysiology into clinical trials, specifically harnessing their immunosuppressive function to prevent graft versus host disease in patients following bone marrow transplantation.